Duniya daya fada daya
─ Haɗin gwiwar kasa da kasa don gina al'ummar duniya makoma guda ɗaya don amsa kalubalen COVID-19.
Labarin cutar coronavirus da ke mamaye duniya ya haifar da ci gaba da rikicin COVID-19 na duniya na cutar sankara.Labarin coronavirus ba shi da iyaka, babu wata ƙasa da za ta tsira daga wannan yaƙin da ake yi da COVID-19.Dangane da wannan cutar ta COVID-19 ta duniya, Liming Bio-Products Corp tana ba da gudummawa don tallafawa jin daɗin al'ummominmu na duniya.
Duniyar mu a halin yanzu tana fuskantar tasirin cutar sankara na 2019 (COVID-19) wanda ba a taɓa ganin irinsa ba.Ya zuwa yau, babu wani ingantaccen magani da ake samu don maganin wannan cuta.Koyaya, an haɓaka gwaje-gwajen bincike da yawa don gano COVID-19.Waɗannan gwaje-gwajen sun dogara ne akan hanyoyin ƙwayoyin cuta ko hanyoyin serological don gano sabon coronavirus takamaiman acid nucleic ko magungunan ƙwayoyin cuta.Kamar yadda COVID-19 ya kai matsayin annoba, farkon gano cutar ƙwayar cuta ta coronavirus yana da mahimmanci wajen tantance yaduwar ƙwayar cuta da ɗauke da ita, amma cikakkiyar gwaji don amfanin duniya bai wanzu ba.Dole ne mu san irin gwaje-gwajen da za a iya amfani da su don dubawa, ganewar asali, da sa ido kan kamuwa da cutar COVID-19, da menene iyakokin su.Yana da matukar muhimmanci yadda za a yi amfani da waɗannan kayan aikin kimiyya da kyau da kuma taimakawa ganowa da sarrafa bullar wannan cuta mai saurin yaɗuwa kuma mai tsanani.
Manufar gano sabon coronavirus shine don tantance ko mutumin da ke da kamuwa da cuta ta COVID-19 ko mai ɗauke da asymptotic wanda zai iya yada kwayar cutar cikin shiru, don ba da mahimman bayanai don jagorantar yanke shawara don magani na asibiti.Nazarin da suka gabata sun nuna cewa kashi 70% na yanke shawara na asibiti sun dogara da sakamakon gwaji.Lokacin da aka yi amfani da hanyoyi daban-daban na ganowa, buƙatun kayan aikin ganowa suma sun bambanta.
Hoto 1
Hoto1:Zane yana nuna maɓalli na matakan matakan ƙididdiga na gabaɗaya yayin yanayin lokacin kamuwa da COVID-19.X-axis yana nuna adadin kwanakin kamuwa da cuta, kuma Y-axis yana nuna nauyin kwayar cutar hoto, ƙaddamar da antigens, da ƙaddamar da ƙwayoyin rigakafi a lokuta daban-daban.Antibody yana nufin IgM da IgG rigakafi.Dukansu RT-PCR da gano antigen ana amfani dasu don gano kasancewar ko babu sabon coronavirus, wanda shine shaida kai tsaye don gano farkon haƙuri.A cikin mako guda na kamuwa da cutar hoto, an fi son gano PCR, ko gano antigen.Bayan kamuwa da cutar coronavirus na novel na kusan kwanaki 7, rigakafin IgM akan novel coronavirus ya karu a hankali a cikin jinin mara lafiya, amma tsawon rayuwar gajere ne, kuma maida hankalinsa yana raguwa da sauri.Sabanin haka, maganin rigakafi na IgG akan kwayar cutar yana bayyana daga baya, yawanci kusan kwanaki 14 bayan kamuwa da cutar.Matsakaicin IgG yana ƙaruwa a hankali, kuma yana daɗe na tsawon lokaci a cikin jini.Don haka, idan an gano IgM a cikin jinin mara lafiya, yana nufin cewa kwayar cutar ta kamu da kwanan nan, wanda shine alamar kamuwa da cuta ta farko.Lokacin da aka gano maganin rigakafi na IgG a cikin jinin majiyyaci, yana nufin cewa kamuwa da cuta ya daɗe na ɗan lokaci.Ana kuma kiran shi marigayi infection ko ciwon baya.Ana ganin sau da yawa a cikin marasa lafiya waɗanda ke cikin lokacin dawowa.
Biomarkers na novel coronavirus
Novel coronavirus ƙwayar cuta ce ta RNA, wacce ta ƙunshi sunadarai da acid nucleic.Kwayar cutar ta mamaye jikin mai gida (dan adam), ta shiga cikin sel ta hanyar daurin wurin da ya dace da mai karɓa ACE2, kuma ta yi kwafi a cikin sel masu masauki, yana sa tsarin garkuwar jikin ɗan adam ya ba da amsa ga maharan na waje da kuma samar da takamaiman ƙwayoyin rigakafi.Don haka, vial nucleic acid da antigens, da takamaiman ƙwayoyin rigakafi da ke kan novel coronavirus za a iya amfani da su azaman takamaiman alamomin halittu don gano sabon coronavirus.Don gano acid nucleic, fasahar RT-PCR ita ce aka fi amfani da ita, yayin da ake amfani da hanyoyin serological don gano takamaiman ƙwayoyin rigakafin coronavirus.A halin yanzu, akwai hanyoyin gwaji iri-iri da ake da su waɗanda za mu iya zaɓar don gwada kamuwa da COVID-19 [1].
Ka'idodin asali na manyan hanyoyin gwaji don sabon coronavirus
Yawancin gwaje-gwajen bincike na COVID_19 suna samuwa ya zuwa yanzu, tare da ƙarin kayan gwaji suna karɓar izini ƙarƙashin izinin amfani da gaggawa kowace rana.Kodayake sabbin ci gaban gwajin da ke fitowa da sunaye da tsari daban-daban, duk gwajin COVID_19 na yanzu ya dogara da manyan fasahohi guda biyu: gano acid nucleic don kwayar cutar ta RNA da serological immunoassays waɗanda ke gano takamaiman takamaiman ƙwayoyin cuta (IgM da IgG).
01. Gano sinadarin Nucleic acid
Reverse transcription-polymerase chain reaction (RT-PCR), madauki-mediated isothermal amplification (LAMP), da jerin tsararraki na gaba (NGS) sune hanyoyin gama gari na acid nucleic don gano sabon coronavirus RNA.RT-PCR shine nau'in gwaji na farko don COVID-19, wanda Hukumar Lafiya ta Duniya (WHO) da Cibiyar Kula da Cututtuka ta Amurka (CDC) suka ba da shawarar.
02.Serological antibody ganowa
Antibody furotin ne mai kariya da aka samar a jikin ɗan adam don mayar da martani ga kamuwa da ƙwayoyin cuta.IgM shine farkon nau'in antibody yayin da IgG shine nau'in antibody daga baya.Ana yin gwajin maganin jini ko samfurin plasma yawanci don kasancewar takamaiman nau'ikan IgM da IgG na rigakafin don kimanta yanayin matsanancin kamuwa da cutar COVID-19.Waɗannan hanyoyin gano tushen rigakafin sun haɗa da gwajin immunochromatography na colloidal zinariya, latex ko fluorescent microsphere immunochromatography, enzyme-linked immunosorbent assay (ELISA), da kuma chemiluminescence assay.
03.Viral antigen ganowa
Antigen wani tsari ne akan kwayar cutar da jikin dan adam ya gane wanda ke haifar da tsarin kariya don samar da kwayoyin rigakafi don share kwayar cutar daga jini da kyallen takarda.Ana iya niyya da gano kwayar cutar antigen ta kwayar cutar ta amfani da immunoassay.Kamar kwayar cutar RNA, kwayar cutar antigens suma suna nan a cikin sassan numfashi na mutanen da suka kamu da cutar kuma ana iya amfani da su don tantance mummunan yanayin kamuwa da COVID-19.Don haka, ana ba da shawarar tattara samfuran numfashi na sama kamar su miya, nasopharyngeal da swabs na oropharyngeal, sputum mai zurfi, ruwan lavage ruwa na bronchoalveolar (BALF) don gwajin antigen na farko.
Zaɓi hanyoyin gwaji don novel coronavirus
Zaɓin hanyar gwaji ya ƙunshi abubuwa da yawa, gami da saitin asibiti, sarrafa ingancin gwaji, lokacin juyawa, farashin gwaji, hanyoyin tattara samfura, buƙatun fasaha na ma'aikatan dakin gwaje-gwaje, kayan aiki da buƙatun kayan aiki.Gano acid nucleic ko kwayar cutar antigens shine don ba da shaida kai tsaye na kasancewar ƙwayoyin cuta da kuma tabbatar da gano cutar kamuwa da cuta ta coronavirus.Kodayake akwai hanyoyi da yawa don gano antigen, ƙwarewar gano su na sabon coronavirus ya kasance ƙasa da na haɓakawa na RT-PCR.Gwajin rigakafin cuta shine gano ƙwayoyin rigakafin ƙwayoyin cuta da aka samar a cikin jikin ɗan adam, waɗanda ke da ƙasa akan lokaci kuma galibi ba za a iya amfani da su ba don ganowa da wuri yayin lokacin kamuwa da cutar.Saitin asibiti don aikace-aikacen ganowa na iya bambanta, kuma wuraren tattara samfurin na iya bambanta.Don gano ƙwayoyin nucleic acid da antigens, ana buƙatar tattara samfurin a cikin sassan numfashi inda kwayar cutar ta kasance, irin su nasopharyngeal swabs, oropharyngeal swabs, sputum, ko bronchoalveolar lavage fluid (BALF).Don gano tushen rigakafin, ana buƙatar tattara samfurin jini kuma a bincika don kasancewar takamaiman anti-virus antibody (IgM/IgG).Koyaya, sakamakon gwajin antibody da nucleic acid na iya haɗawa da juna.Misali, lokacin da sakamakon gwajin ya kasance kwayar nucleic acid-negative, IgM-negative amma IgG-tabbatacce, wadannan sakamakon sun nuna cewa mara lafiyar a halin yanzu ba ya dauke da kwayar cutar, amma an dawo da shi daga kamuwa da cutar coronavirus.[2]
Fa'idodi da rashin amfanin gwajin coronavirus novel
A cikin ka'idar bincike da jiyya don Novel Coronavirus Pneumonia (Trial Version7) (Hukumar Lafiya ta Kasa da Hukumar Kula da Magungunan Gargajiya ta Sin ta Saki a ranar 3 ga Maris, 2020), ana amfani da gwajin acid nucleic azaman hanyar ma'aunin gwal don tantance littafin. kamuwa da cutar coronavirus, yayin da kuma ana ɗaukar gwajin rigakafin a matsayin ɗayan hanyoyin tabbatar da ganewar asali.
Abubuwan da aka gano na pathogenic da serological
(1) Abubuwan da aka gano na cutarwa: Za a iya gano novel coronavirus nucleic acid a cikin swabs na nasopharyngeal, sputum, ƙananan ɓoyayyun hanyoyin numfashi, jini, najasa da sauran samfuran ta amfani da hanyoyin RT-PCRand/ko NGS.Ya fi daidai idan an samo samfurori daga ƙananan hanyoyin numfashi (sputum ko cirewar iska).Ya kamata a gabatar da samfuran don gwaji da wuri-wuri bayan an tattara su.
(2) Binciken serological: ƙwayar cuta ta NCP takamaiman IgM ta zama abin ganowa a kusa da kwanaki 3-5 bayan farawa;IgG ya kai titration na aƙalla haɓaka ninki 4 yayin kwanciyar hankali idan aka kwatanta da babban lokaci.
Koyaya, zaɓin hanyoyin gwaji ya dogara da wuraren yanki, ƙa'idodin likita, da saitunan asibiti.A cikin Amurka, NIH ta ba da Jagororin Jiyya na Cutar Coronavirus 2019 (COVID-19) (An sabunta shi: Afrilu 21,2020) da FDA ta ba da Manufofin Gwajin Ganewa na Cutar Coronavirus-2019 yayin Gaggawar Kiwon Lafiyar Jama'a (an bayar a ranar Maris 16,2020). ), wanda gwajin serological na ƙwayoyin rigakafi na IgM/IgG aka zaɓa kawai azaman gwajin nunawa.
Hanyar Gano Acid Nucleic
RT_PCR gwajin nucleic acid ne mai tsananin raɗaɗi wanda aka ƙera don gano ko sabon coronavirus RNA yana cikin numfashi ko wani samfurin.Kyakkyawan sakamakon gwajin PCR yana nufin kasancewar novel coronavirus RNA a cikin samfurin don tabbatar da kamuwa da cutar COVID-19.Sakamakon gwajin PCR mara kyau baya nufin rashin kamuwa da kwayar cutar saboda rashin ingancin samfurin zai iya shafar shi a lokacin da aka dawo da shi, da sauransu.Ko da yake RT-PCR gwaji ne mai mahimmanci, yana da nakasuwa da yawa.Gwajin RT-PCR na iya zama mai ɗaukar aiki da ɗaukar lokaci, mai mahimmanci ya dogara da ingancin samfurin.Wannan na iya zama ƙalubale saboda adadin kwayar cutar RNA ba wai kawai ya bambanta sosai tsakanin majiyyata daban-daban ba amma kuma yana iya bambanta tsakanin majiyyaci ɗaya dangane da lokutan lokacin da aka tattara samfurin da kuma matakan kamuwa da cuta ko farkon alamun asibiti.Gano sabon coronavirus yana buƙatar samfurori masu inganci waɗanda ke ɗauke da isassun adadin RNA mara lafiya.
Gwajin RT-PCR na iya ba da sakamako mara kyau (mara kyau na ƙarya) ga wasu marasa lafiya waɗanda ke da kamuwa da COVID-19.Kamar yadda muka sani, manyan wuraren kamuwa da cuta na novel coronavirus suna cikin huhu da ƙananan hanyoyin numfashi, kamar alveoli da bronchi.Saboda haka, samfurin sputum daga tari mai zurfi ko kuma ruwan lavage ruwa na bronchoalveolar (BALF) ana ɗauka yana da mafi girman hankali don gano cutar hoto.Duk da haka, a cikin aikin asibiti, ana tattara samfurori sau da yawa daga sararin samaniya ta hanyar amfani da nasopharyngeal ko swabs na oropharyngeal.Tattara waɗannan samfuran ba kawai rashin jin daɗi ba ne ga marasa lafiya amma kuma yana buƙatar ma'aikata na musamman.Don yin samfurin ya zama ƙasa da ɓarna ko sauƙi, a wasu lokuta ana iya ba marasa lafiya swab na baka kuma a basu damar ɗaukar samfurin daga mucosa na buccal ko harshe suna shafa kansu.Ba tare da isassun RNA na hoto ba, RT-qPCR na iya dawo da sakamakon gwaji mara kyau.A lardin Hubei, na kasar Sin, an ba da rahoton hankalin RT-PCR a farkon ganowar kusan kashi 30% -50%, tare da matsakaicin kashi 40%.An yi yuwuwa yawan adadin ƙarancin ƙirƙira ya haifar da rashin isassun samfuri.
Bugu da kari, gwajin RT-PCR yana buƙatar ƙwararrun ma'aikata don yin hadaddun matakan cirewar RNA da tsarin haɓaka PCR.Hakanan yana buƙatar babban matakin kariyar biosafety, kayan aikin dakin gwaje-gwaje na musamman, da kayan aikin PCR na gaske.A cikin kasar Sin, gwajin RT-PCR don gano COVID-19 yana buƙatar yin shi a cikin dakunan gwaje-gwaje na matakin 2 (BSL-2), tare da kariyar ma'aikata ta amfani da aikin matakin biosafety 3 (BSL-3).A karkashin wadannan bukatu, daga farkon watan Janairu zuwa farkon Fabrairu 2020, karfin dakin gwaje-gwajen CDC na kasar Sin na Wuhan ya iya gano wasu lokuta dari kadan a kowace rana.A al'ada, wannan ba zai zama matsala ba lokacin gwada wasu cututtuka masu yaduwa.Koyaya, lokacin da ake mu'amala da annoba ta duniya kamar COVID-19 tare da yuwuwar miliyoyin mutane da za a gwada, RT-PCR ta zama matsala mai mahimmanci saboda buƙatunta na kayan aikin gwaje-gwaje na musamman ko kayan fasaha.Waɗannan lahani na iya iyakance RT-PCR don amfani da shi azaman ingantaccen kayan aiki don tantancewa, kuma yana iya haifar da jinkiri a cikin rahotannin sakamakon gwaji.
Hanyar gano ƙwayar cuta ta serological
Tare da ci gaban yanayin cutar, musamman a cikin matakai na tsakiya da na ƙarshe, ƙimar ganowar rigakafin ƙwayoyin cuta yana da yawa sosai.Wani bincike da aka yi a Asibitin Tsakiyar Kudu na Wuhan ya nuna cewa adadin gano maganin rigakafin na iya kaiwa sama da kashi 90% a cikin mako na uku na kamuwa da cutar COVID-19.Hakanan, maganin rigakafi shine samfurin martanin rigakafin ɗan adam akan sabon coronavirus.Gwajin antibody yana ba da fa'idodi da yawa akan RT-PCR.Na farko, serological antibody yana gwada sauƙi da sauri.Za a iya amfani da gwaje-gwajen kwararar jini na gefen gaba don kulawa don isar da sakamako cikin mintuna 15.Na biyu, makasudin da gwajin serological ya gano shi ne maganin rigakafi, wanda aka sani ya fi kwanciyar hankali fiye da kwayar cutar RNA.Yayin tattarawa, jigilar kaya, ajiya da gwaji, samfuran gwajin rigakafin gabaɗaya sun fi kwanciyar hankali fiye da samfuran RT-PCR.Na uku, saboda antibody yana rarraba daidai gwargwado a cikin jini, ana samun ƙarancin bambance-bambancen samfur idan aka kwatanta da gwajin nucleic acid.Girman samfurin da ake buƙata don gwajin rigakafin ƙwayoyin cuta kaɗan ne.Misali, microliter 10 na jinin hatsakin yatsa ya wadatar don amfani a gwajin kwararar antibody.
Gabaɗaya, an zaɓi gwajin rigakafin mutum azaman ƙarin kayan aiki don gano acid nucleic don haɓaka ƙimar gano sabon coronavirus yayin darussan cutar.Lokacin da aka yi amfani da gwajin rigakafin tare da gwajin acid nucleic, yana iya haɓaka daidaiton ƙididdiga don gano cutar ta COVID19 ta rage yuwuwar sakamako mai inganci da na ƙarya.Jagorar aiki na yanzu baya bada shawarar yin amfani da nau'ikan gwaji guda biyu daban azaman tsarin ganowa mai zaman kansa amma yakamata a yi amfani dashi azaman tsarin haɗin gwiwa.[2]
Hoto2:Madaidaicin fassarar nucleic acid da sakamakon gwajin antibody don gano sabon kamuwa da cutar coronavirus
Hoto na 3:Liming Bio-Products Co., Ltd. - Novel coronavirus IgM/IgG antibody dual fast test Kit (StrongStep)®SARS-CoV-2 IgM/IgG Gwajin Saurin Gwajin Antibody, Latex Immunochromatography)
Hoto na 4:Liming Bio-Products Co., Ltd. - StrongStep®Novel Coronavirus (SARS-CoV-2) Multiplex Real-Time PCR kit (gane ga kwayoyin halitta guda uku, hanyar bincike mai kyalli).
Lura:Wannan kayan aikin PCR mai mahimmanci, shirye-shiryen amfani yana samuwa a cikin tsarin lyophilized (tsarin bushewa daskarewa) don adana dogon lokaci.Ana iya jigilar kayan kuma a adana shi a zazzabi na ɗaki kuma ya tsaya tsayin daka har tsawon shekara guda.Kowane bututu na premix ya ƙunshi duk abubuwan da ake buƙata don haɓakawa na PCR, gami da Reverse-transcriptase, Taq polymerase, primers, probes, da dNTPs substrates. Masu amfani za su iya sake haɗawa kawai ta hanyar ƙara ruwa mai daraja na PCR tare da samfuri sannan lodi. a kan kayan aikin PCR don gudanar da haɓakawa.
Dangane da barkewar cutar sankara ta coronavirus, Liming Bio-Products Co., Ltd. ya yi aiki cikin sauri don haɓaka na'urorin bincike guda biyu don ba da damar dakunan gwaje-gwajen kiwon lafiya na asibiti da na jama'a don gano cutar COVID-19 cikin sauri.Waɗannan na'urorin sun dace sosai don amfani da su don yin gwaje-gwaje masu girma a cikin ƙasashe da yankuna inda sabon labari na coronavirus ke yaduwa cikin sauri, da kuma samar da bincike da tabbatarwa ga kamuwa da cutar COVID-19.Waɗannan kayan aikin don amfani ne kawai a ƙarƙashin Izinin Amfani da Gaggawa da aka riga aka sanar (PEUA).Gwaji yana iyakance ga dakunan gwaje-gwaje da aka tabbatar a ƙarƙashin ƙa'idodin hukumomin ƙasa ko na gida.
Hanyar gano antigen
1. An rarraba gano maganin ƙwayar cuta ta ƙwayar cuta a cikin nau'in ganowa kai tsaye kamar gano nucleic acid.Waɗannan hanyoyin gano kai tsaye suna neman shaidar cututtukan ƙwayoyin cuta a cikin samfurin kuma ana iya amfani da su don tabbatar da ganewar asali.Koyaya, haɓaka kayan gano antigen yana buƙatar babban ingancin ƙwayoyin rigakafi na monoclonal tare da ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan ƙaƙƙarfan hankali da kuma azanci mai ƙarfi wanda zai iya ganewa da ɗaukar ƙwayoyin cuta.Yawancin lokaci yana ɗaukar fiye da watanni shida don zaɓar da haɓaka maganin rigakafin monoclonal wanda ya dace don amfani a cikin shirye-shiryen kayan gano antigen.
2. A halin yanzu, reagents don gano kai tsaye na novel coronavirus har yanzu suna ƙarƙashin bincike da matakin haɓakawa.Don haka, babu kayan gano antigen da aka inganta ta asibiti kuma ana samun su ta kasuwanci.Ko da yake a baya an ba da rahoton cewa wani kamfanin bincike a Shenzhen ya ƙera na'urar gano antigen kuma an gwada shi a asibiti a Spain, ba za a iya tabbatar da amincin kima da daidaito ba saboda kasancewar abubuwan ingancin reagent.Har zuwa yau, NMPA (tsohuwar FDA ta kasar Sin) ba ta amince da kowane kayan gano antigen don amfani da asibiti ba tukuna.A ƙarshe, an ƙirƙiri hanyoyin gano iri-iri.Kowace hanya tana da fa'ida da gazawarta.Ana iya amfani da sakamakon daga hanyoyi daban-daban don tabbatarwa da haɓakawa.
3. Samar da kayan gwajin COVID-19 mai inganci ya dogara sosai akan ingantawa yayin bincike da haɓakawa.Kudin hannun jari Liming Bio-Product Co., Ltd.Ana buƙatar kayan gwaji don saduwa da ƙwaƙƙwaran masana'antu da ka'idodin kula da inganci don tabbatar da cewa sun samar da mafi girman matakan aiki da daidaito.Masana kimiyya a Liming Bio-Product Co., Ltd. suna da gogewar sama da shekaru ashirin a ƙira, gwaji, da haɓaka kayan bincike na in vitro don tabbatar da mafi girman matakin aiki a ƙididdige ƙididdigewa.
A yayin barkewar cutar numfashi ta COVID-19, gwamnatin kasar Sin ta fuskanci karuwar bukatar kayayyakin rigakafin annoba a wuraren da ake fama da cutar a duniya.A ranar 5 ga Afrilu, a taron manema labarai na hadin gwiwa na rigakafin rigakafi da sarrafa kayan aikin Majalisar Jiha "Ƙarfafa Gudanar da Ingantattun Kayan Kiwon Lafiyar Kiwon Lafiyar Kiwon Lafiyar Kiwon Lafiyar Kiwon Lafiyar Kiwon Lafiyar Kiwon Lafiya da Kayyade oda na Kasuwa", Jiang Fan, babban jami'in sifeto na ma'aikatar harkokin waje ta ma'aikatar harkokin waje. na Kasuwanci, ya ce, "Na gaba, za mu mai da hankali kan kokarinmu a kan bangarori biyu, na farko, don gaggauta tallafin karin kayayyakin jinya da kasashen duniya ke bukata, da kuma inganta ingancin sarrafawa, tsari, da sarrafa kayayyakin. Za mu ba da gudummawar da Sin za ta bayar wajen tinkarar annobar duniya baki daya, da gina al'umma mai makoma guda ga bil'adama.
Hoto na 5:Liming Bio-Products Co., Ltd.'s novel coronavirus reagent ya sami takardar shaidar rajista ta EU CE
Takardar girmamawa
Houshenshan
Hoto 6. Liming Bio-Products Co., Ltd. ya tallafa wa Asibitin Dutsen Wuhan Vulcan (HouShenShan) don yaki da annobar COVID-19 kuma an ba shi takardar shaidar girmamawa ta Wuhan Red Cross.Asibitin dutsen Wuhan Vulcan shine sanannen asibiti a kasar Sin wanda ya kware wajen kula da masu fama da cutar COVID-19 mai tsanani.
Yayin da barkewar cutar sankara ke ci gaba da yaduwa a duniya, Nanjing Liming Bio-Products Co., Ltd. Yana tashi tsaye don tallafawa da taimakawa al'ummomin duniya tare da sabbin fasahohinmu don yakar wannan barazanar da ba a taba gani ba a duniya.Gwajin saurin kamuwa da cutar COVID-19 muhimmin bangare ne na magance wannan barazanar.Muna ci gaba da ba da gudummawa ta hanya mai mahimmanci ta hanyar samar da ingantattun dandamali na bincike a hannun ma'aikatan kiwon lafiya na gaba don mutane su sami mahimman sakamakon gwajin da suke buƙata.Ƙoƙarin Liming Bio-products Co., Ltd. a yaƙin cutar ta COVID-19 shine don ba da gudummawar fasahohinmu, gogewa, da ƙwarewarmu ga al'ummomin duniya don gina al'ummar duniya ta makoma.
Dogon Latsa ~ Duba kuma ku Bi Mu
Imel: sales@limingbio.com
Yanar Gizo: https://limingbio.com
Lokacin aikawa: Mayu-01-2020
